Start-up
ImevaX GmbH
Pylori DuoTect® - Facilitating H. pylori diagnosis
About ImevaX
ImevaX, based in Munich, Germany, is a biopharmaceutical company specializing in the development, manufacture and worldwide distribution of Pylori DuoTect®.
Pylori DuoTect® is a highly effective and cost-efficient in vitro rapid test for the qualitative determination of specific antibodies against two H. pylori antigens in human whole blood, serum or plasma: FliD and CagA.
This test allows the initial diagnosis of H. pylori infection in adult individuals and provides a reliable result within only 20 minutes. This greatly facilitates decision making for healthcare professionals for further diagnostic or therapeutic measures.
Pylori DuoTect® is designed for both point-of-care (POC) and laboratory use and is manufactured in Germany.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
- Focus : Manufacturer
- Industry : Pharma
- DIN EN ISO 13485
Here you will find ImevaX GmbH
See the theme worlds for related content
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.
